TEVA
TEVA
US8816242098
Teva Pharmaceutical Industries
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
47.93B EUR
39.48B EUR
35.07B EUR
35.89B EUR
Enterprise Value
58.98B EUR
52.7B EUR
48.24B EUR
49.42B EUR
Valuation Multiples
Trailing P/E
68.5x
55.92x
22.42x
30.03x
Forward P/E
13.29x
--
--
--
Price to Sales
2.77x
2.28x
2.02x
2.68x
Price to Book
6.18x
5.09x
4.26x
4.54x
EV/Revenue
3.41x
3.04x
2.78x
3.7x
EV/EBITDA
13.82x
12.49x
9.77x
12.51x
Price to FCF (P/FCF)
21.59x
29.29x
29.93x
26x
EV/FCF
26.57x
39.09x
41.16x
35.81x
FCF Yield
4.63%
3.41%
3.34%
3.85%
ende